Cargando…

How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?

Detalles Bibliográficos
Autores principales: Kathirgamakarthigeyan, Sangary, Foweraker, Karen, Johnson, Kerstie, Sivanandan, M. Ananth, Pascoe, Abigail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829818/
http://dx.doi.org/10.1016/S0169-5002(22)00075-7
_version_ 1784648148127318016
author Kathirgamakarthigeyan, Sangary
Foweraker, Karen
Johnson, Kerstie
Sivanandan, M. Ananth
Pascoe, Abigail
author_facet Kathirgamakarthigeyan, Sangary
Foweraker, Karen
Johnson, Kerstie
Sivanandan, M. Ananth
Pascoe, Abigail
author_sort Kathirgamakarthigeyan, Sangary
collection PubMed
description
format Online
Article
Text
id pubmed-8829818
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88298182022-02-10 How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre? Kathirgamakarthigeyan, Sangary Foweraker, Karen Johnson, Kerstie Sivanandan, M. Ananth Pascoe, Abigail Lung Cancer COVID and Cancer Elsevier B.V. Published by Elsevier B.V. 2022-03 2022-02-10 /pmc/articles/PMC8829818/ http://dx.doi.org/10.1016/S0169-5002(22)00075-7 Text en Copyright © 2022 Elsevier B.V. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle COVID and Cancer
Kathirgamakarthigeyan, Sangary
Foweraker, Karen
Johnson, Kerstie
Sivanandan, M. Ananth
Pascoe, Abigail
How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title_full How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title_fullStr How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title_full_unstemmed How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title_short How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre?
title_sort how has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (nsclc) in our centre?
topic COVID and Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829818/
http://dx.doi.org/10.1016/S0169-5002(22)00075-7
work_keys_str_mv AT kathirgamakarthigeyansangary howhasthecoronaviruspandemicimpactedchemoradiotherapyforstage3nonsmallcelllungcancernsclcinourcentre
AT fowerakerkaren howhasthecoronaviruspandemicimpactedchemoradiotherapyforstage3nonsmallcelllungcancernsclcinourcentre
AT johnsonkerstie howhasthecoronaviruspandemicimpactedchemoradiotherapyforstage3nonsmallcelllungcancernsclcinourcentre
AT sivanandanmananth howhasthecoronaviruspandemicimpactedchemoradiotherapyforstage3nonsmallcelllungcancernsclcinourcentre
AT pascoeabigail howhasthecoronaviruspandemicimpactedchemoradiotherapyforstage3nonsmallcelllungcancernsclcinourcentre